Scancell
Prof. Lindy Gillian Durrant Ph.D. (Founder, CEO, Chief Scientific Officer & Director)
Dr. Sally Elizabeth Adams (Chief Devel. Officer & Director)
Mr. Keith Green (Director of Fin. & Admin. and Company Sec.)
Summary
History
Scancell is a world-leading bio-medical company focused on the development of novel immunotherapies for the treatment of cancer and associated diseases. The company was founded in 2001 by Professor Lindy Durrant, who recognised the potential of novel monoclonal antibody-based therapies, and is now backed by a clinical research and development team of experienced thought-leaders from the drug development sector. Scancell has a strong track record of success in product development and clinical validation, having successfully delivered a range of innovative products for patients through seeking regulatory approval and global partnerships.
Mission
Vision
Key Team
Dr. Samantha Paston Ph.D. (Head of Translational Research)
Dr. Adrian Parry Ph.D. (Head of Manufacturing)
Ms. Akua Asare (Head of Quality)
Mr. Fayaz Master (Head of Clinical Operations)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Prof. Lindy Gillian Durrant Ph.D. (Founder, CEO, Chief Scientific Officer & Director)
Dr. Sally Elizabeth Adams (Chief Devel. Officer & Director)
Mr. Keith Green (Director of Fin. & Admin. and Company Sec.)